All lobbying filings

VIATRIS INC.

VIATRIS INC. filed a Q4 report for VIATRIS INC on January 20, 2026.

Lobbying for VIATRIS INC

All filings by VIATRIS INC. · Everything VIATRIS INC has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Expenses

$490,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 6

Defense

S.2296 National Defense Authorization Act

Budget/Appropriations

HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)

Health Issues

S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act

IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act

Trade (domestic/foreign)

Trade issues related to generic medicines Pharmaceutical supply chain

Financial Institutions/Investments/Securities

Policy related to corporate governance

Bills named in this filing 8

S. 2296
National Defense Authorization Act for Fiscal Year 2026
H.R. 9747
Continuing Appropriations and Extensions Act, 2025
S. 891
Bipartisan Health Care Act
H.R. 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
S. 1302
Increasing Transparency in Generic Drug Applications Act
H.R. 4132
Prescription Information Modernization Act of 2025
S. 2027
Prescription Information Modernization Act of 2025
S. 2658
Medication Affordability and Patent Integrity Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.